Abstract
Distinguishing one type of dementia from another may be difficult without running many tests. However, distinguishing dementia from delirium or some other non-dementia condition presenting similar symptoms as those seen in dementia is crucial since such symptoms may be reversible after treatment. Delirium, for example, can usually be traced to a contributing factor such as medications, brain trauma, alcohol or drug abuse, surgery, infection, and a host of medical illnesses associated with high fever. Fever can cause delirium because high temperature (105 °F and over) can interfere with multiple processes involving brain metabolism.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jingami N, Asada-Utsugi M, Uemura K, Noto R, Takahashi M, Ozaki A, Kihara T, Kageyama T, Takahashi R, Shimohama S, Kinoshita A. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer’s disease. J Alzheimers Dis. 2015;45(1):109–15.
Duthie A, Chew D, Soiza RL. Non-psychiatric comorbidity associated with Alzheimer’s disease. QJM. 2011;104(11):913–20.
Ryan M, Merrick EL, Hodgkin D, Horgan CM, Garnick DW, Panas L, Ritter G, Blow FC, Saitz R. Drinking patterns of older adults with chronic medical conditions. J Gen Intern Med. 2013;28(10):1326–32.
Molino I, Colucci L, Fasanaro AM, Traini E, Amenta F. Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer’s disease: a review of clinical trials. Sci World J. 2013;29(2013):925702.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess. 2012;16(21):1–470.
Casey DA, Antimisiaris D, O’Brien J. Drugs for Alzheimer’s disease: are they effective? Pharm Ther. 2010;35(4):208–11.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
de la Torre, J.C. (2016). Masquerading as Dementia. In: Alzheimer’s Turning Point. Springer, Cham. https://doi.org/10.1007/978-3-319-34057-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-34057-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34056-2
Online ISBN: 978-3-319-34057-9
eBook Packages: MedicineMedicine (R0)